ATA240692A - Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat - Google Patents

Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat

Info

Publication number
ATA240692A
ATA240692A AT0240692A AT240692A ATA240692A AT A240692 A ATA240692 A AT A240692A AT 0240692 A AT0240692 A AT 0240692A AT 240692 A AT240692 A AT 240692A AT A240692 A ATA240692 A AT A240692A
Authority
AT
Austria
Prior art keywords
ranitide
inismutcitrate
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
AT0240692A
Other languages
English (en)
Other versions
AT401468B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ATA240692A publication Critical patent/ATA240692A/de
Application granted granted Critical
Publication of AT401468B publication Critical patent/AT401468B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT0240692A 1991-12-06 1992-12-04 Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat AT401468B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (2)

Publication Number Publication Date
ATA240692A true ATA240692A (de) 1996-02-15
AT401468B AT401468B (de) 1996-09-25

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0240692A AT401468B (de) 1991-12-06 1992-12-04 Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat

Country Status (26)

Country Link
US (1) US5466436A (de)
EP (1) EP0550083B1 (de)
JP (1) JPH05246853A (de)
KR (1) KR930009605A (de)
AP (1) AP324A (de)
AT (1) AT401468B (de)
AU (1) AU664574B2 (de)
BE (1) BE1007268A3 (de)
CA (1) CA2084568A1 (de)
CH (1) CH685537A5 (de)
CZ (1) CZ358092A3 (de)
DE (1) DE69228738D1 (de)
DK (1) DK0550083T3 (de)
ES (1) ES2130152T3 (de)
FR (1) FR2684554B1 (de)
GB (1) GB2262036B (de)
GR (1) GR3030426T3 (de)
IE (1) IE922866A1 (de)
IL (1) IL103978A (de)
IT (1) IT1256697B (de)
LU (1) LU88196A1 (de)
MX (1) MX9207008A (de)
MY (1) MY108146A (de)
NO (1) NO303670B1 (de)
NZ (1) NZ245365A (de)
PH (1) PH31380A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
EP0941102A1 (de) * 1996-11-22 1999-09-15 The Procter & Gamble Company Zusammensetzungen zur behandlung von gastrointestinalen störungen, welche wismuth und einen nsaid enthalten
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DK1411900T4 (da) * 2001-06-01 2014-01-27 Pozen Inc Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
WO2007012019A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
EP2063873A2 (de) * 2006-08-31 2009-06-03 Horizon Therapeutics, Inc. Nsaid-dosierungseinheitsformulierungen mit h2-rezeptor-antagonisten und verfahren zu ihrer verwendung
KR20110079641A (ko) 2008-09-09 2011-07-07 아스트라제네카 아베 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
IN171746B (de) * 1989-11-02 1992-12-26 Mcneil Ppc Inc
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
MX9207008A (es) 1993-06-01
CA2084568A1 (en) 1993-06-07
NO303670B1 (no) 1998-08-17
DK0550083T3 (da) 1999-10-11
DE69228738D1 (de) 1999-04-29
FR2684554B1 (fr) 1995-09-08
NO924704L (no) 1993-06-07
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
GB9225174D0 (en) 1993-01-20
PH31380A (en) 1998-10-29
AP324A (en) 1994-03-07
KR930009605A (ko) 1993-06-21
IE922866A1 (en) 1993-06-16
ITRM920869A1 (it) 1994-06-04
IL103978A0 (en) 1993-05-13
NZ245365A (en) 1997-06-24
ES2130152T3 (es) 1999-07-01
GB2262036B (en) 1996-01-03
AU664574B2 (en) 1995-11-23
AP9200453A0 (en) 1993-01-31
ITRM920869A0 (it) 1992-12-04
IT1256697B (it) 1995-12-12
FR2684554A1 (fr) 1993-06-11
JPH05246853A (ja) 1993-09-24
IL103978A (en) 1998-06-15
GB2262036A (en) 1993-06-09
BE1007268A3 (fr) 1995-05-09
AT401468B (de) 1996-09-25
US5466436A (en) 1995-11-14
EP0550083A1 (de) 1993-07-07
MY108146A (en) 1996-08-30
CZ358092A3 (en) 1993-10-13
NO924704D0 (no) 1992-12-04
GR3030426T3 (en) 1999-09-30
EP0550083B1 (de) 1999-03-24
LU88196A1 (fr) 1993-08-17

Similar Documents

Publication Publication Date Title
ATA129892A (de) Pharmazeutische zusammensetzung
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI981777A0 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
ATE203400T1 (de) Pharmazeutische formulierungen
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FI923582A7 (fi) Farmaseuttinen sferoidikoostumus
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
BR9200058A (pt) Composto e composicao farmaceutica
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
FI893643A7 (fi) Farmaseuttisia koostumuksia
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
ATE142880T1 (de) Penciclovir enthaltende pharmazeutische formulierung
FI921785A7 (fi) Farmaceutisk foerening
FI921786A7 (fi) Farmaceutisk foerening
FI923869L (fi) Farmaceutiska aemnen
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FI910773A7 (fi) Episialo-hiilihydraattikompleksia sisältävä farmaseuttinen koostumus
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
ATA31798A (de) Pharmazeutische zusammensetzung enthaltend ciclosporin

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee